BMJ Open · 2021 · 29 citations · 15 references
BusinessInsuranceInternal MedicineClinical EpidemiologyEpidemiologyHealth InsuranceAnalytic EpidemiologyDiabetes MellitusLife Table AnalysisMortality AnalysisMortality MeasurementMortality ModelingAge-adjusted RateAge-specific Mortality ChangeAge-specific Mortality RatesClaims Mortality AnalysisDiabetes MortalityInsurance Claim AnalysisInsurance Claims DataInternational Classification Of Diseases
OBJECTIVES: Little is known about the age-specific excess mortality pattern of people with diagnosed diabetes in Germany. Thus, our goal was to determine the excess mortality in diagnosed diabetes overall and stratified by age and sex based on claims data. DESIGN: Routine data analysis using a claims dataset from all statutory health-insured persons in Germany in 2013, which accounts for about 90% of the population. PARTICIPANTS: We included persons who lived in Germany, were insured at least 360 days, were not self-paying any health services and were aged 30 years or older leading to a total number of 47.3 million insured persons for analyses. EXPOSURE: Diabetes was determined by the International Classification of Diseases-10 codes E10-E14, which were documented in 2013 in at least two-quarters on an outpatient setting or at least once on an inpatient setting. OUTCOME MEASURES: The vital status in the study population was drawn from the claims dataset for the year 2014. We derived the excess mortality estimated as an age-adjusted mortality rate ratio (MRR) by sex and for age groups using a Poisson model. MAIN RESULTS: We found age-adjusted MRRs (95% CI) for diabetes of 1.52 (1.51 to 1.52) for women and 1.56 (1.56 to 1.56) for men. These figures declined with increasing age and were highest for ages 30-34 years with 6.76 (4.99 to 9.15) for women and 6.87 (5.46 to 8.64) for men, and lowest for age 95 years and older with 1.13 (1.10 to 1.15) for women and 1.11 (1.05 to 1.17) for men. CONCLUSIONS: We derived deeply age-stratified figures on excess mortality in diabetes for Germany. Establishing a sustainable analysis of excess mortality is aimed at within the framework of diabetes surveillance.
15
Excess Mortality among Persons with Type 2 Diabetes
Mauro Tancredi, Annika Rosengren, Ann‐Marie Svensson et al. · New England Journal of Medicine · 2015 · 1K citations · Full text
Edward W. Gregg, Yiling J. Cheng, Meera Srinivasan et al. · The Lancet · 2018 · 489 citations · Full text
Public Health, Health Sciences, Population Health Sciences +17
Teresa Tamayo, Ralph Brinks, Annika Hoyer et al. · Deutsches Ärzteblatt international · 2016 · 180 citations
Medicine, Health Policy, Insurance +17